JPWO2023145812A1 - - Google Patents
Info
- Publication number
- JPWO2023145812A1 JPWO2023145812A1 JP2023576973A JP2023576973A JPWO2023145812A1 JP WO2023145812 A1 JPWO2023145812 A1 JP WO2023145812A1 JP 2023576973 A JP2023576973 A JP 2023576973A JP 2023576973 A JP2023576973 A JP 2023576973A JP WO2023145812 A1 JPWO2023145812 A1 JP WO2023145812A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01045—Glucosylceramidase (3.2.1.45), i.e. beta-glucocerebrosidase
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022013048 | 2022-01-31 | ||
| PCT/JP2023/002409 WO2023145812A1 (ja) | 2022-01-31 | 2023-01-26 | グルコセレブロシダーゼ活性を有する糖鎖付加タンパク質 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023145812A1 true JPWO2023145812A1 (https=) | 2023-08-03 |
| JPWO2023145812A5 JPWO2023145812A5 (https=) | 2024-09-26 |
Family
ID=87471497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023576973A Pending JPWO2023145812A1 (https=) | 2022-01-31 | 2023-01-26 |
Country Status (3)
| Country | Link |
|---|---|
| US (1) | US20250145978A1 (https=) |
| JP (1) | JPWO2023145812A1 (https=) |
| WO (1) | WO2023145812A1 (https=) |
Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003008431A1 (en) * | 2001-06-19 | 2003-01-30 | Otsuka Chemical Co.,Ltd. | Process for producing sugar chain asparagine derivative |
| WO2005010053A1 (ja) * | 2003-07-28 | 2005-02-03 | Otsuka Chemical Co., Ltd. | アミノ化複合型糖鎖誘導体及びその製造方法 |
| JP2014500722A (ja) * | 2010-11-08 | 2014-01-16 | カリダス・バイオファーマ，インコーポレーテッド | 増加した安定性および増加した保持触媒活性を有する変異型組換えβ−グルコセレブロシダーゼタンパク質 |
| WO2014157107A1 (ja) * | 2013-03-29 | 2014-10-02 | 株式会社糖鎖工学研究所 | シアリル化糖鎖が付加されたポリペプチド |
| WO2020157248A1 (en) * | 2019-02-01 | 2020-08-06 | Oxyrane Uk Ltd | Glucocerebrosidase polypeptides |
| WO2021048034A1 (en) * | 2019-09-09 | 2021-03-18 | F. Hoffmann-La Roche Ag | Glucocerebrosidase mutants |
| WO2021199039A1 (en) * | 2020-03-29 | 2021-10-07 | Yeda Research And Development Co. Ltd. | Variants of beta-glucocerebrosidase for use in treating gaucher disease |
-
2023
- 2023-01-26 WO PCT/JP2023/002409 patent/WO2023145812A1/ja not_active Ceased
- 2023-01-26 JP JP2023576973A patent/JPWO2023145812A1/ja active Pending
- 2023-01-26 US US18/833,876 patent/US20250145978A1/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2003008431A1 (en) * | 2001-06-19 | 2003-01-30 | Otsuka Chemical Co.,Ltd. | Process for producing sugar chain asparagine derivative |
| WO2005010053A1 (ja) * | 2003-07-28 | 2005-02-03 | Otsuka Chemical Co., Ltd. | アミノ化複合型糖鎖誘導体及びその製造方法 |
| JP2014500722A (ja) * | 2010-11-08 | 2014-01-16 | カリダス・バイオファーマ，インコーポレーテッド | 増加した安定性および増加した保持触媒活性を有する変異型組換えβ−グルコセレブロシダーゼタンパク質 |
| WO2014157107A1 (ja) * | 2013-03-29 | 2014-10-02 | 株式会社糖鎖工学研究所 | シアリル化糖鎖が付加されたポリペプチド |
| WO2020157248A1 (en) * | 2019-02-01 | 2020-08-06 | Oxyrane Uk Ltd | Glucocerebrosidase polypeptides |
| WO2021048034A1 (en) * | 2019-09-09 | 2021-03-18 | F. Hoffmann-La Roche Ag | Glucocerebrosidase mutants |
| WO2021199039A1 (en) * | 2020-03-29 | 2021-10-07 | Yeda Research And Development Co. Ltd. | Variants of beta-glucocerebrosidase for use in treating gaucher disease |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2023145812A1 (ja) | 2023-08-03 |
| US20250145978A1 (en) | 2025-05-08 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240703 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240703 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250722 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20251216 |